BALAMINES logo

Balaji Amines Limited

BALAMINES·NSE·
₹2,048.70▼ -29.90 (-1.44%)
Market Cap6694.69 Cr
PE Ratio39.70
Volume1,04,056
Day High - Low2103.00 - 2037.20
52W High-Low2629.80 - 968.10

Balaji Amines Limited (BALAMINES): company summary

The company's annual revenue rose 2.6% to ₹1,425 crore, while net profit increased 6.4% to ₹169 crore.

Balaji Amines Limited (BALAMINES) is a small-cap Chemicals company valued at ₹6,695 crore operating in Specialty Chemicals on the NSE and BSE.

Recent price move
Balaji Amines Limited last traded at ₹2,048.7, modestly down 1.44% on the day.
Recent developments
On 2026-07-03, the company announced a dividend of ₹11.00 per share, ex-date. Promoter shares pledged increased to 17.68% of promoter holding as of 2026-06-30. Foreign institutional holding rose 0.19 percentage points to 3.17%, while domestic institutional holding increased 0.13 percentage points to 1.59%.
Financial performance
The company's annual revenue rose 2.6% to ₹1,425 crore, while net profit increased 6.4% to ₹169 crore. The latest quarter saw revenue jump 27.4% to ₹456 crore and net profit surge 111.1% to ₹78 crore, indicating strong seasonal performance. The net profit margin improved by 0.4 percentage points to 11.9%, but the three-year profit CAGR of -25.3% suggests declining profitability over time.
Valuation multiples
The stock trades at 39.7 times earnings, 3.84 times book value. It yields 0.5%.
Things to watch
The stock is 22.0% below its 52-week high, and the five-year profit CAGR of -7.0% shows declining earnings. The three-year revenue CAGR of -15.3% indicates weakening growth. Promoter shares pledged account for 17.68% of their holding, which may signal liquidity concerns.
Where it stands
Balaji Amines Limited ended the latest quarter with revenue of ₹456 crore and net profit of ₹78 crore, showing a sharp rise compared to the same quarter a year earlier. The stock is 22.0% below its 52-week high, and the company's profit margin improved slightly to 11.9%. The company remains almost debt-free with a debt-to-equity ratio of 0.07.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
3.7/10
Poor
Fair Value
Sign in to see
ROE
8.56%
Average
P/E
39.70x
Expensive
Debt / Equity
0.07
Low
Industry
Chemicals
Specialty Chemicals
Overall View
Poor

Price performance

Day₹2037
₹2103
52W₹968.10
₹2630
DocStoX take

Supported by risk (7.2) and momentum (7.1), but held back by valuation (0.8).

DocStoX score

Low confidence
3.7
/10
Poor
Quality
Modest
ROE 8.6%
Valuation
Expensive
P/E 39.7×
Growth
Flat
Revenue +1.7% 5Y CAGR
Risk
Moderate
D/E 0.07
Momentum
Firm
65% of 52-week range

At a glance

Market Cap
₹6,695 Cr
52W High / Low
₹2630 / ₹968
Dividend Yield
0.47%
Promoter Holding
54.56%
EPS (TTM)
₹51.60
Book Value
₹610.00

Key highlights

  • Low leverage — D/E 0.07
  • Profitable in all of the last 5 years
  • Profit shrinking 7% a year
  • 18% of promoter holding is pledged
2 Positives4 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Chemicals stocks · Specialty Chemicals

Balaji Amines Limited peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.